نتایج جستجو برای: intravesical instillation

تعداد نتایج: 6985  

2016
Keitaro Iida Taku Naiki Noriyasu Kawai Toshiki Etani Ryosuke Ando Yosuke Ikegami Takehiko Okamura Hiroki Kubota Atsushi Okada Kenjiro Kohri Takahiro Yasui

BACKGROUND The purpose of this study was to assess the efficacy of Bacillus Calmette-Guerin (BCG) therapy after a second transurethral resection (TUR) in new onset high-grade T1 bladder cancer. METHODS From January 2008 to September 2013, 207 patients with new onset high-grade T1 bladder cancer after an initial TUR were treated at our university and at affiliated hospitals. Residual cancer ra...

Journal: :Urology journal 2007
Aliasghar Yarmohammadi Hassan Ahmadinia Mehran Abolbashari Mahmood Molaei

Received October 2006 Accepted March 2007 INTRODUCTION Intravesical instillation of bacillus Calmette-Guerin (BCG) is a known treatment method in superficial bladder cancers after transurethral resection of the bladder tumor (TURBT).(1) Moreover, its polysaccharide nucleotide is used in the treatment of asthma.(2) However, the most familiar usage of the BCG to the public is vaccination against ...

Journal: :Actas urologicas espanolas 2011
T F Palma A Seabra S C Souto L Maciel M Alvarenga R Siniscalchi M Ganzarolli C Ricetto

PURPOSE The aim of this study is to develop a new experimental model of inducing interstitial cystitis (IC) through vesical instillation of a polymeric solution containing the NO donor S-nitrousglutathione (GSNO) and to compare it to the experimental interstitial cystitis induced by vesical instillation of protamine and potassium chloride. MATERIAL AND METHOD For that purpose 40 female Wistar...

2016
SHANG-JUN JIANG LI-YIN YE FAN-HUA MENG

The aim of the present meta-analysis was to compare the benefits of Bacillus Calmetter-Guerin (BCG) and mitomycin C in the treatment of patients with superficial bladder cancer. The present meta-analysis analyzed the benefits of BCG and mitomycin C in the treatment of patients with superficial bladder cancer by comparing progression-free survival (PFS) rates in patients treated with either of t...

Journal: :The Journal of clinical investigation 2005
Masaki Nogawa Takeshi Yuasa Shinya Kimura Motoyoshi Tanaka Junya Kuroda Kiyoshi Sato Asumi Yokota Hidekazu Segawa Yoshinobu Toda Susumu Kageyama Tatsuhiro Yoshiki Yusaku Okada Taira Maekawa

The mainstay in the management of invasive bladder cancer continues to be radical cystectomy. With regard to improvement of quality of life, however, therapies that preserve the bladder are desirable. We investigated the use of intravesical PLK-1 small interfering RNA (siRNA) against bladder cancer. Patients with bladder cancers expressing high levels of PLK-1 have a poor prognosis compared wit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید